SIRO Clinpharm announces the opening of its new office in Hyderabad, India. 

"Hyderabad has always had a vibrant biopharmaceutical ecosystem and we believe that SIRO Clinpharm can actively contribute to the global industry with the expansion of our local operations. With our expanding footprint, we broaden our value proposition and bring a unique competitive advantage to the table," said Mr Partha Chatterjee, head, clinical research and clinical trial supplies management.

"The clinical research industry has its niche, which requires specialised talent and Hyderabad, being a lifesciences hub, attracts highly qualified professionals from across the country. Our new office gives us access to this talent pool, which is imperative to ensure that we are providing our clients with world class services," said Dr Vatsal Shah, vice president and global head, medical writing, biometrics and pharmacovigilance.

In addition to their wide operational presence across the globe, SIRO also has access to a large database of investigators and is one of the few CROs to have a dedicated feasibility team.